Ledger.Open graph →
SEC Form D · Amendment · filed September 20, 2010

EIGER BIOPHARMACEUTICALS INC

Offering
$8.3M
Sold
$8.3M
Exemption
Industry
Biotechnology
Location
PALO ALTO, CA
Type

People & firms on this filing (15)

David Cory · Palo Alto, CAExec · DirectorJeffrey Glenn · Palo Alto, CADirectorGlen Sato · Palo Alto, CAExecEd Engleman · Palo Alto, CADirectorPaul Truex · Palo Alto, CADirectorNina Kjellson · Palo Alto, CADirectorKeith Vendola · Palo Alto, CAExecWilliam F. Ball Iii · Warrenton, VAExec · DirectorBrian Beverly · Des Moines, IADirectorRobert D. Grote · Des Moines, IADirectorJeanne K. Johnson · Des Moines, IADirectorEsplin Keith · Rexburg, IDDirectorLaura G. King · Madison, WIExecKeith Vendola · St. Louis, MOExecWenjin Yang · Palo Alto, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗